Ainos, Inc. Profile Avatar - Palmy Investing

Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test manag…

Biotechnology
US, San Diego [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Ainos, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
14,086,300
Volume
128,627
Volume on Avg.
601,126
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $0.67 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of AIMD's Analysis
CIK: 1014763 CUSIP: 00902F105 ISIN: US00902F3038 LEI: - UEI: -
Secondary Listings
AIMD has no secondary listings inside our databases.